Saraf and Partners

Arbitration has become the preferred mode of dispute resolution in commercial disputes due to its efficiency, confidentiality, and party autonomy.

Saraf and Partners advises Metropolis Healthcare Limited on its acquisition of Agra-based Scientific Pathology via a slump sale, through its wholly owned subsidiary Metropolis Clinical Pathology Private Limited.

Saraf and Partners advised Systematix Corporate Services Ltd, Batlivala & Karani Securities India Private Limited, Emkay Global Financial Services Ltd, IDBI Capital Markets & Securities Ltd. and Motilal Oswal Investment Advisors Limited in relation to the qualified institutional placement (“QIP”) by Central Bank of India (“Bank”).

Saraf and Partners advised Indian Overseas Bank (“IOB”) in its qualified institutional placement (“QIP”) of equity shares aggregating to INR 14,368.98 million.

Saraf and Partners acts for AMPIN Energy Transition Private Limited (AMPIN) in a fund raise of USD 50 Million from Siemens Financial Services, the financing arm of Siemens AG (Siemens). Siemens subscribed to a mix of equity shares and preference shares of AMPIN for its capital infusion.

Saraf and Partners is pleased to announce the joining of Raunaq Bahadur Mathur as a Partner in its Dispute Resolution practice, based out of the firm’s Delhi office.

New Delhi, India, March 28, 2025: Saraf and Partners acted for AMPIN Energy Transition Private Limited (AMPIN) in a fund raise of USD 50 Million from Siemens Financial Services, the financing arm of Siemens AG (Siemens).

Fortis Hospotel Limited, a wholly-owned subsidiary of Fortis Healthcare Limited,